|
|
name  click to compare prices |
» Shop local, ethical and at the best price on Ethishop  |
|
| |
|
Business & marketSubsidiaries
| shareholder | country | % | source |
|
| country | address & contact : production type incentive source |
 China | Pekin : Production, Centre de R&D Les Echos |
|
| year name | photo position; compensation source |
| 2002Collier, Earl |  Vice-president; salary: 0.5 million US$; Company |
| 2002Wirth, Peter | Vice-president; salary: 0.66 million US$; Company |
|
year | employees <> | social impact : country source |
|
| year | employees <> | social impact : country source |
|
| year | financial misdemeanor | sales | income | | buyback | source |
| 2008 |
| 4.61 | 0.42 | | | billion US$ | Company |
| 2007 |
| 3.81 | 0.48 | | | billion US$ | Company |
| 2007 |
| | | | 1.5 | billion US$ | Company |
| 2006 |
| 3.19 | -0.02 | | | billion US$ | Company |
| 2003 |
| 1.71 | -0.07 | | | billion US$ | Company |
| 2003 |
Genzyme's abuse of its dominant market position has prevented viable competition and choice. |
| | | | | | The Guardian |
| 2002 |
| 1.33 | -0.01 | | | billion US$ | Company |
| 2001 |
| 1.22 | -0.11 | | | billion US$ | Company |
| 2000 |
| 0.9 | -0.06 | | | billion US$ | Company |
| 1998 |
| 0.69 | 0.06 | | | billion US$ | Company |
|
| year | financial misdemeanor | sales | income | assets | buyback | source |
|
| year | purpose : intermediary/lobby : institution source |
| 2000 | Limit the legal liability, no price control, no list of preferred drugs, hampers the approval and marketing of generic drugs, no drug imports, no limit to drug advertising… : Pharmaceutical Research and Manufacturers of America : : US government, congress, senate  translate | Washington Post |
| 1999 | Market admission for genetically modified organisms : EuropaBio : : European Commission translate | Corporate Europe Observatory |
|
| year | purpose : intermediary/lobby : institution source |
|
|
|
Contribute
&sa=OK&client=pub-2642534665785160&forid=1&channel=6290198667&ie=ISO-8859-1&oe=ISO-8859-1&flav=0002&sig=NuXwWEvBGZspbgPc&cof=GALT%3A%23CEA7FF%3BGL%3A1%3BDIV%3A%234A4A4A%3BVLC%3AFF6600%3BAH%3Acenter%3BBGC%3A4A4A4A%3BLBGC%3A4A4A4A%3BALC%3AFFB42D%3BLC%3AFFB42D%3BT%3AFFFFFF%3BGFNT%3AE8DBEF%3BGIMP%3ACEA7FF%3BLH%3A26%3BLW%3A304%3BL%3Ahttp%3A%2F%2Fwww.transnationale.org%2Fimages%2Ftrans2.gif%3BS%3Ahttp%3A%2F%2Fwww.transnationale.org%3BFORID%3A11&hl=en){kind=link}
&sa=OK&client=pub-2642534665785160&forid=1&channel=6290198667&ie=ISO-8859-1&oe=ISO-8859-1&flav=0002&sig=NuXwWEvBGZspbgPc&cof=GALT%3A%23CEA7FF%3BGL%3A1%3BDIV%3A%234A4A4A%3BVLC%3AFF6600%3BAH%3Acenter%3BBGC%3A4A4A4A%3BLBGC%3A4A4A4A%3BALC%3AFFB42D%3BLC%3AFFB42D%3BT%3AFFFFFF%3BGFNT%3AE8DBEF%3BGIMP%3ACEA7FF%3BLH%3A26%3BLW%3A304%3BL%3Ahttp%3A%2F%2Fwww.transnationale.org%2Fimages%2Ftrans2.gif%3BS%3Ahttp%3A%2F%2Fwww.transnationale.org%3BFORID%3A11&hl=en){kind=link}
